Answers are grounded in this paper and cite their sources.
The clinical utility of μ-opioid receptor (MOR) agonists is limited by side effects and tolerance. G protein βγ subunits (Gβγ) are critical mediators of MOR signaling that not only drive anticonception but also regulate phospholipase C and G protein-coupled receptor kinase pathways that feedback and inhibit MOR signaling. Modulation of Gβγ signaling with small molecules to preferentially inhibit feedback inhibition of MOR has been proposed as a strategy to enhance analgesia without exacerbating adverse effects. In this study, we investigated mechanisms by which gallein, a small-molecule Gβγ signaling modulator, enhances MOR-mediated antinociception in vivo. Gallein pretreatment significantly enhanced the antinociceptive effects of different MOR agonists and nonopioid analgesics that act through Gi-coupled G protein-coupled receptors, with the strongest effects observed upon coadministration with morphine. Gallein-mediated enhancement of morphine-induced antinociception was abolished by the opioid antagonist naloxone and was absent in MOR knockout mice. Notably, systemic naloxone methiodide, which cannot cross the blood-brain barrier, did not prevent gallein-mediated enhancement of morphine-induced antinociception. Intracerebroventricular, but not intrathecal, administration of gallein enhanced morphine-induced antinociception. Gallein was also effective at enhancing the action of morphine in a hot plate assay, implicating supraspinal MOR dependency. Lastly, 10 S/T-A mice expressing phosphosite-deficient MORs lost responsiveness to gallein treatment, supporting a mechanism of action in which gallein inhibits Gβγ-dependent inhibitory feedback phosphorylation of MOR in the central nervous system. SIGNIFICANCE STATEMENT: These findings provide insight into the mechanisms for potentiation of the antinociceptive effects of μ-opioid receptor (MOR) agonists via modulation of G protein βγ (Gβγ) signaling pathways. The study demonstrates dependence on central MORs and requires the ability of MOR to be feedback-regulated through phosphorylation. Pharmacological modulation of Gβγ signaling could serve as effective adjuncts to traditional opioid therapy.
No takes yet. Share an insight, caveat, or question.
Ormes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: